Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pNO colorectal cancer

International Journal of Colorectal Disease

Volumn 19, Issue 5, 2004, Pages 430-437

  Rosenberg, Robert ^a   Friederichs, Jan ^a   Gertler, Ralf ^a   Hoos, Axel ^a   Mueller, James ^a   Nahrig, Jorg ^a   Nekarda, Hjalmar ^a   Siewert, Joerg Ruediger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colorectal cancer; Disseminated tumor cells; Immunohistochemistry; Lymph nodes

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER EP4; MONOCLONAL ANTIBODY CK20; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REVIEW; SURVIVAL TIME; TUMOR LOCALIZATION;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 4444307057     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GD, Crucitti F (1998) Prognostic factors in colorectal cancer. Dis Colon Rectum 41:1033-1049
2. Goldstein NS, Sanford W, Coffey M, Layfield LJ (1996) Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 106:209-216
3. Bilchik AJ, Nora DT, Sobin LH, Turner RR, Trocha S, Krasne D, Morton DL (2003) Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol 21:668-672
4. Caplin S, Cerottini J-P, Bosman FT, Constanda MT, Givel J-C (1998) For patients with Dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 83:666-672
5. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer 88:1739-1757
6. Hammond ME, Fitzgibbons PL, Compton CC, Grignon DJ, Page DL, Fielding LP. Bostwick D, Pajak TF (2000) College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Arch Pathol Lab Med 124:958-965
7. Knebel Doeberitz M von, Koch M, Weitz J, Herfarth C (2000) Diagnostik und Bedeutung der "Minimal Residual Disease" bei Patienten mit kolorektalem Karzinom. Zentralbl Chir 125 [Suppl 1]:15-19
8. Izbicki JR, Hosch SB (2000) Die Rolle von immunhistochemisch detektierbaren Tumorzellen in Lymphknoten. Zentralbl Chir 125:796-798
9. Rosenberg R, Nekarda H, Thorban S, Siewert JR (2002) Minimal residual disease in gastrointestinal tumors: tumor cell detection in bone marrow, blood and lymph nodes. Acta Med Austriaca 29 [Suppl 59]: 42-53
10. Calaluce R, Miedema BW, Yesus YW (1998) Micrometastasis in colorectal carcinoma: a review. J Surg Oncol 67:194-202
11. Makin CA, Bobrow LG, Nicholls RJ (1989) Can immunohistology improve detection of lymph-node metastases in large-bowel cancer? Dis Colon Rectum 32:99-102
12. Chan J (2000) Advances in immunohistochemistry: impact on surgical pathology practice. Semin Diagn Pathol 17:170-177
13. Van Wyk Q, Hosie KB, Balsitis M (2000) Histopathological detection of lymph node metastases from colorectal carcinoma. J Clin Pathol 53:685-687
14. Ghossein RA, Bhattacharya S (2000) Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 36:1681-1694
15. Rosenberg R, Hoos A, Mueller J, Nekarda H (2000) Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 83:1323-1329
16. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H, Siewert JR (2002) The prognostic significance of cytokeratin-20 RT-PCR in lymph nodes of node negative (pN0) colorectal cancer patients. J Clin Oncol 20:1049-1055
17. Hermanek P, Hutter RV, Sobin LH, Wittekind C (1999) Classification of isolated tumor cells and micrometastasis. Cancer 86:2668-2673
18. Schlag PM (1998) The "sentinel node" concept: more questions raised than provided? Oncologist 3:VI-VII
19. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS (2001) Molecular staging of early colon cancer on the basis of sentinel lymph node analysis: a multicenter phase II trial. J Clin Oncol 19:1128-1136
20. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, Desai D, Kaushal S, Nagaraju M, Arora M, Singh T (2000) Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 7:120-124
21. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T (2001) Ex vivo sentinel mapping in carcinoma of the colon and rectum. Ann Surg 233:515-521
22. Wood TF, Tsioulias GJ, Morton DL, Rangel D, Hutchinson W, Foshag LJ, Turner RR, Bilchik AJ (2000) Focused examination of sentinel lymph nodes upstages early colorectal carcinoma. Am Surg 66:998-1003
23. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ (2000) Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 135:926-932
24. Kienle P, Koch M (2001) Minimal residual disease in gastrointestinal cancer. Semin Surg Oncol 20:282-293
25. Greenson JK, Isenhart CE, Rice R, Majzisik C, Houchens D, Martin EW (1994) Identification of occult micrometastases in pericolic lymph nodes of Dukes B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 73:563-569
26. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, Hatakeyama K (1997) Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in " node-negative" colorectal cancer. J Gastroenterol 32:758-764
27. Clarke G, Ryan E, O'Keane JC, Crowe J, MacMathuna P (2000) The detection of cytokeratins in lymph nodes of Dukes' B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 12:549-552
28. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S (2001) Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 8:300-304
29. Davidson B, Smas V, Styles J, Deane C, Boulos P (1990) Detection of occult metastases in patients with colorectal carcinoma. Cancer 65:967-970
30. Cutait R, Venancio A, Lopes L, Cutait D, Borges J, Singer J, da Silva J, Goffi F (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917-920
31. Haboubi NY, Clark P, Kaftan SM, Schofield PF (1992) The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85:386-388
32. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M (1994) The prognostic significance of immunohistochemically detected colorectal carcinoma. J Pathol 172:183-187
33. Nicholson AG, Marks CG, Cook MG (1994) Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut 35:1447-1448
34. Adell G, Boeryd B, Franlund B, Sjödahl R, Hakansson L (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162:637-642
35. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch HP, Duchrow M (1997) Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 40:1465-1471
36. Oeberg A, Stenling R, Tavelin B, Lindmark G (1998) Are lymph node micrometastases of any clinical significance in Dukes stage A and B colorectal cancer? Dis Colon Rectum 41:1244-1249
37. Hitchcock CL, Sampsel J, Young DC, Martin EW Jr, Arnoöd MW (1999) Limitations with light microscopy in the detection of colorectal cancer cells. Dis Colon Rectum 42:1046-1052
38. Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S (1999) Clinical implications of lymph node micrometastases in patients with colorectal cancers. Oncology 57:276-280
39. Tschmelitsch J, Klimstra DS, Cohen AM (2000) Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 7:601-608
40. Noura S, Yamamoto H, Miyake Y, Kim B, Takayama O, Seshimo I, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M (2002) Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res 8:759-767
41. Choi HJ, Choi YY, Hong SH (2002) Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 45:750-755
42. Tsavallas G, Patel H, Allen-Mersh (2001) Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Cancer 88:1307-1320
43. O'Brien MJ, Zamcheck N, Burke B, Kirkham SE, Saravis CA, Gottlieb LS (1981) Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Am J Clin Pathol 75:283-290
44. Moll R, Löwe A, Laufer J, Franke W (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-447